Viridian Therapeutics, Inc.
VRDN
$12.38
-$0.43-3.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 636.63M | 717.58M | 753.24M | 571.37M | 613.19M |
| Total Receivables | -- | -- | 14.00K | -- | 102.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.61M | 20.88M | 14.10M | 10.30M | 13.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 657.24M | 738.46M | 767.36M | 581.66M | 626.82M |
|
|
|||||
| Total Current Assets | 657.24M | 738.46M | 767.36M | 581.66M | 626.82M |
| Net Property, Plant & Equipment | 3.25M | 3.44M | 3.69M | 3.34M | 3.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 489.00K | 501.00K | 853.00K | 659.00K | 555.00K |
| Total Assets | 660.98M | 742.40M | 771.90M | 585.66M | 630.38M |
|
|
|||||
| Total Accounts Payable | 3.89M | 2.14M | 6.34M | 3.14M | 2.68M |
| Total Accrued Expenses | 28.92M | 44.83M | 34.05M | 29.76M | 22.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 536.00K | 513.00K | 589.00K | 3.47M | 732.00K |
| Total Finance Division Other Current Liabilities | 388.00K | 388.00K | 388.00K | 388.00K | 388.00K |
| Total Other Current Liabilities | 388.00K | 388.00K | 388.00K | 388.00K | 388.00K |
| Total Current Liabilities | 33.73M | 47.87M | 41.36M | 36.76M | 26.13M |
|
|
|||||
| Total Current Liabilities | 33.73M | 47.87M | 41.36M | 36.76M | 26.13M |
| Long-Term Debt | 20.69M | 20.58M | 20.52M | 17.49M | 20.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.88M | 2.02M | 2.16M | 1.65M | 896.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 212.00K | 284.00K | 356.00K | 429.00K | 500.00K |
| Total Liabilities | 56.51M | 70.76M | 64.40M | 56.33M | 47.85M |
|
|
|||||
| Common Stock & APIC | 1.50B | 1.48B | 1.43B | 1.17B | 1.16B |
| Retained Earnings | -1.08B | -995.86M | -916.13M | -839.44M | -774.45M |
| Treasury Stock & Other | 245.00K | -10.00K | 932.00K | -543.00K | -367.00K |
| Total Common Equity | 415.59M | 482.75M | 518.61M | 329.63M | 382.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 188.89M | 188.89M | 188.89M | 199.71M | 199.71M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 188.89M | 188.89M | 188.89M | 199.71M | 199.71M |
|
|
|||||
| Total Common Equity | 415.59M | 482.75M | 518.61M | 329.63M | 382.82M |
| Total Preferred Equity | 188.89M | 188.89M | 188.89M | 199.71M | 199.71M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 604.47M | 671.64M | 707.50M | 529.34M | 582.53M |
|
|
|||||